Mark A Watson Selected Research

Estrogens (Estrogen)

5/2009	PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer.
2/2004	Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark A Watson Research Topics

Disease

35	Neoplasms (Cancer) 01/2024 - 03/2002
13	Breast Neoplasms (Breast Cancer) 01/2024 - 02/2004
8	Colorectal Neoplasms (Colorectal Cancer) 10/2008 - 01/2003
6	Neoplasm Metastasis (Metastasis) 03/2020 - 01/2003
5	Adenocarcinoma 01/2023 - 08/2008
3	Adenocarcinoma of Lung 03/2020 - 12/2007
3	Neurofibrosarcoma (MPNST) 04/2011 - 07/2004
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023 - 01/2019
2	Carcinoma (Carcinomatosis) 01/2019 - 06/2012
2	Brain Neoplasms (Brain Tumor) 01/2018 - 03/2002
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 08/2006
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2009 - 06/2009
2	Acute Promyelocytic Leukemia 06/2009 - 02/2007
2	Meningioma (Meningiomas) 08/2005 - 08/2002
2	Adenoma (Adenomas) 04/2005 - 03/2002
1	Pathologic Complete Response 01/2024
1	Residual Neoplasm 01/2024
1	Glucose Intolerance 01/2023
1	Circulating Neoplastic Cells 01/2023
1	Lung Diseases (Lung Disease) 01/2021
1	COVID-19 01/2021
1	Lung Neoplasms (Lung Cancer) 11/2020
1	Obesity 01/2020
1	Inflammation (Inflammations) 01/2020
1	Insulin Resistance 01/2020
1	Kidney Calculi (Kidney Stone) 01/2019
1	Gout 01/2019
1	Disease Progression 01/2018
1	Atrophy 06/2012
1	Sarcoma (Soft Tissue Sarcoma) 04/2011
1	Acinar Cell Carcinoma 10/2009
1	Metaplasia 08/2009
1	Genetic Translocation (Chromosomal Translocation) 06/2009
1	Leukemia 06/2009
1	Heart Failure 03/2009
1	Cardiomyopathies (Cardiomyopathy) 03/2009
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2008

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2002
11	RNA (Ribonucleic Acid)IBA 01/2024 - 10/2002
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2005
8	Messenger RNA (mRNA)IBA 11/2020 - 02/2004
8	DNA (Deoxyribonucleic Acid)IBA 09/2013 - 12/2007
5	Estrogen ReceptorsIBA 01/2024 - 05/2009
3	Trastuzumab (Herceptin)FDA Link 01/2020 - 08/2009
3	ErbB Receptors (EGF Receptor)IBA 10/2008 - 03/2006
3	OligonucleotidesIBA 03/2006 - 08/2002
2	Phenobarbital (Luminal)FDA Link 01/2024 - 06/2011
2	Anastrozole (Arimidex)FDA LinkGeneric 01/2024 - 06/2011
2	Insulin (Novolin)FDA Link 01/2023 - 01/2020
2	LipidsIBA 01/2020 - 06/2006
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 06/2006
2	AcidsIBA 01/2020 - 09/2008
2	Transcription Factors (Transcription Factor)IBA 10/2015 - 12/2007
2	Complement System Proteins (Complement)IBA 09/2009 - 08/2009
2	Progesterone Receptors (Progesterone Receptor)IBA 08/2009 - 02/2004
2	Estrogens (Estrogen)FDA Link 05/2009 - 02/2004
2	A-Form DNA (A-DNA)IBA 10/2008 - 03/2002
2	ApolipoproteinsIBA 06/2006 - 05/2003
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2004 - 08/2002
1	Fulvestrant (Faslodex)FDA Link 01/2024
1	Superoxides (Superoxide)IBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2023
1	Blood Proteins (Serum Proteins)IBA 01/2021
1	HLA-DR Antigens (HLA-DR)IBA 01/2021
1	Long Noncoding RNAIBA 03/2020
1	9-hydroxy-10,12-octadecadienoic acidIBA 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020
1	Dietary Fats (Dietary Fat)IBA 01/2020
1	Linoleic Acid (Linoleate)IBA 01/2020
1	Uric Acid (Urate)IBA 01/2019
1	B7-H1 AntigenIBA 01/2019
1	LigandsIBA 01/2019
1	Estrogen Receptor alphaIBA 01/2018
1	CytoglobinIBA 06/2012
1	N(w)-nitroarginine benzyl ester (NABE)IBA 06/2012
1	exemestane (Aromasin)FDA Link 06/2011
1	Letrozole (Femara)FDA LinkGeneric 06/2011
1	Aromatase InhibitorsIBA 06/2011
1	Forkhead Box Protein M1IBA 04/2011
1	Prolactin Receptors (Prolactin Receptor)IBA 10/2009
1	Keratin-5 (Keratin 5)IBA 08/2009
1	methionylmethionine (Met-Met)IBA 08/2009
1	Retinoic Acid Receptor alphaIBA 06/2009
1	dactolisibIBA 05/2009
1	MicroRNAs (MicroRNA)IBA 03/2009
1	Formaldehyde (Formol)FDA Link 10/2008
1	ParaffinIBA 10/2008
1	Thymidylate SynthaseIBA 10/2008
1	SmokeIBA 10/2008

Therapy/Procedure

11	Therapeutics 01/2023 - 03/2002
5	Drug Therapy (Chemotherapy) 01/2020 - 03/2005
4	Neoadjuvant Therapy 01/2024 - 09/2007
3	Lasers (Laser) 06/2012 - 01/2005
2	Immunotherapy 01/2023 - 01/2019
1	Oral Administration 01/2023
1	Radiotherapy 01/2018
1	Aftercare (After-Treatment) 06/2011
1	Segmental Mastectomy (Lumpectomy) 06/2011
1	Heart-Assist Devices 03/2009